BTE05NASAL
Immunochromatographic test designed for the qualitative detection in humans of an antigen specific to SARS-CoV-2 in a mucus sample from the anterior nasal vestibule. It is intended to be used by professionals or by the individual as a screening test and as an aid in the early diagnosis of SARS-CoV-2 infection.
- French design and manufacture
- Rapid and reliable detection of SARS-CoV-2 antigens:
Results in 15 minutes
Sensitivity: 91.0%; Specificity: 99.0
Detects N protein and new variants of COVID-19 virus.
- Convenient to use:
Without additional equipment, can be performed by the patient or self-sampled in front of a healthcare professional.
May also be useful to support public health strategies, such as contact tracing and large-scale testing of suspected active cases.
- Sold in boxes of 5
- Contents of one box:
5 test cassettes ;
1 bottle of sample extraction buffer; 5 nasal swabs
5 nasal swabs;
5 sets of extraction and drip tubes;
1 rack
1 Instructions for use
5 bags for disposal after use
Listed by the French Ministry of Health.
Advantages of the product:
- French design and manufacture
- Fast and reliable detection
- Practical to use
- Listed by the French Ministry of Health
| Characteristic | Value |
|---|---|
| Packaging | Box of 5 kits |
In-vitro diagnostic medical device.
In vitro diagnostic medical devices. Classification : Other tests. Read carefully the instructions in the package insert that accompanies the medical device. According to the notice of 11 April 2021, the test is intended for in vitro diagnostic use in self-testing or self-sampling in front of a health professional on a nasal sample. Documentation intended for professionals and the general public. Photographs are not contractual.